Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0IQ0S
|
||||
| Former ID |
DNC010172
|
||||
| Drug Name |
Tyr-Pro-Phe-Ala-Bn
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530314] | ||
| Formula |
C33H39N5O5
|
||||
| Canonical SMILES |
CC(C(=O)NCC1=CC=CC=C1)NC(=O)C(CC2=CC=CC=C2)NC(=O)C3CCCN<br />3C(=O)C(CC4=CC=C(C=C4)O)N
|
||||
| InChI |
1S/C33H39N5O5/c1-22(30(40)35-21-25-11-6-3-7-12-25)36-31(41)28(20-23-9-4-2-5-10-23)37-32(42)29-13-8-18-38(29)33(43)27(34)19-24-14-16-26(39)17-15-24/h2-7,9-12,14-17,22,27-29,39H,8,13,18-21,34H2,1H3,(H,35,40)(H,36,41)(H,37,42)/t22-,27-,28-,29-/m0/s1
|
||||
| InChIKey |
FFJZWXQQTXSXFM-OCDVNBFTSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [530314] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||